Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q4 FY21 results · Jan–Mar 2021
Advanced Enzyme Technologies reported revenue from operations of ₹133.22 crore (up 20.8% from Q4 FY20) and net profit of ₹33.80 crore (up 3.4% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 133.22 | 110.26 | +20.8% | 137.74 | −3.3% |
| Other income | 1.68 | 1.84 | −8.7% | 1.35 | +24.9% |
| Total income | 134.90 | 112.11 | +20.3% | 139.09 | −3.0% |
| Profit before tax | 47.77 | 43.20 | +10.6% | 60.91 | −21.6% |
| Net profit for the period | 33.80 | 32.68 | +3.4% | 44.30 | −23.7% |
| Attributable to shareholders of the company | 31.68 | 31.33 | +1.1% | 43.09 | −26.5% |
| EPS, basic (₹) | 2.84 | 2.81 | +1.1% | 3.86 | −26.4% |
| Net margin (%) | 25.4 | 29.6 | 32.2 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 70.61 | 68.42 | +3.2% | 79.14 | −10.8% |
| Other income | 2.58 | 1.29 | +100.5% | 1.77 | +45.7% |
| Total income | 73.19 | 69.71 | +5.0% | 80.92 | −9.5% |
| Profit before tax | 22.07 | 21.60 | +2.2% | 26.42 | −16.5% |
| Net profit for the period | 15.24 | 16.00 | −4.8% | 20.32 | −25.0% |
| EPS, basic (₹) | 1.37 | 1.43 | −4.2% | 1.82 | −24.7% |
| Net margin (%) | 21.6 | 23.4 | 25.7 |
Consolidated
- Filed with BSE
- 31 May 2021, 09:32 IST
- Board meeting
- 29 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 May 2021, 09:32 IST
- Board meeting
- 29 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE